PMID- 20069279 OWN - NLM STAT- MEDLINE DCOM- 20110615 LR - 20181201 IS - 1432-0738 (Electronic) IS - 0340-5761 (Linking) VI - 84 IP - 3 DP - 2010 Mar TI - A Mechanism for the induction of renal tumours in male Fischer 344 rats by short-chain chlorinated paraffins. PG - 233-43 LID - 10.1007/s00204-009-0489-9 [doi] AB - Short-chain chlorinated paraffins (SCCPs) cause kidney tumours in male rats, but not in female rats or mice of either sex. Male rat-specific tumours also occur in rats dosed with a range of compounds including 1,4- dichlorobenzene (DCB) and d-limonene (DL). These compounds bind to a male rat-specific hepatic protein, alpha-2-urinary globulin (alpha2u), and form degradationresistant complexes in the kidney. The resulting accumulation of alpha2u causes cell death and sustained regenerative cell proliferation, which in turn leads to the formation of renal tumours. To investigate whether the SCCP, Chlorowax 500C (C500C), causes tumours via the accumulation of alpha2u male rats were orally dosed with either C500C (625 mg/kg of body weight), DCB (300 mg/kg of body weight), or DL (150 mg/kg of body weight) for 28 consecutive days. An increase in renal alpha2u and cell proliferation was observed in DCB- and DL-treated rats but not in C500C-treated rats. C500C caused peroxisome proliferation and a down-regulation of alpha2u synthesis in male rat liver. This down-regulation occurred at the transcriptional level. Since less alpha2u was produced in C500C-treated rats, there was less available for accumulation in the kidney hence a typical alpha2u nephropathy did not appear. However, the administration of a radiolabelled SCCP, [14C]polychlorotridecane (PCTD), to male rats demonstrated its binding to renal alpha2u. Thus, it is possible that SCCPs bind to alpha2u and cause a slow accumulation of the protein in the kidney followed by delayed onset of alpha2u nephropathy. As a consequence of these findings in the current experiments, while evidence exists implicating alpha2u-globulin in the molecular mechanism of action of the C500C, the classic profile of a alpha2u-globulin nephropathy seen with other chemicals such as DCB and DL was not reproduced during this experimental protocol. FAU - Warnasuriya, Gayathri D AU - Warnasuriya GD AD - Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 5JJ, UK. FAU - Elcombe, Barbara M AU - Elcombe BM FAU - Foster, John R AU - Foster JR FAU - Elcombe, Clifford R AU - Elcombe CR LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Germany TA - Arch Toxicol JT - Archives of toxicology JID - 0417615 RN - 0 (Alpha-Globulins) RN - 0 (Carcinogens) RN - 0 (Chlorobenzenes) RN - 0 (Cyclohexenes) RN - 0 (Hydrocarbons, Chlorinated) RN - 0 (Terpenes) RN - 0 (alpha 2u globulin) RN - 56509-64-9 (chlorowax 500C) RN - 9MC3I34447 (Limonene) RN - D149TYB5MK (4-dichlorobenzene) SB - IM MH - Alpha-Globulins/genetics/*metabolism MH - Animals MH - Carcinogens/*metabolism/toxicity MH - Cell Proliferation/drug effects MH - Chlorobenzenes/metabolism/toxicity MH - Cyclohexenes/metabolism/toxicity MH - Disease Models, Animal MH - Down-Regulation/drug effects MH - Female MH - Hydrocarbons, Chlorinated/*metabolism/toxicity MH - Kidney/drug effects/metabolism MH - Kidney Neoplasms/chemically induced/*metabolism/pathology MH - Limonene MH - Liver/drug effects/metabolism MH - Male MH - Peroxisomes/drug effects MH - Protein Binding MH - Rats MH - Rats, Inbred F344 MH - Terpenes/metabolism/toxicity MH - Transcription, Genetic/drug effects EDAT- 2010/01/14 06:00 MHDA- 2011/06/16 06:00 CRDT- 2010/01/14 06:00 PHST- 2009/11/06 00:00 [received] PHST- 2009/11/10 00:00 [accepted] PHST- 2010/01/14 06:00 [entrez] PHST- 2010/01/14 06:00 [pubmed] PHST- 2011/06/16 06:00 [medline] AID - 10.1007/s00204-009-0489-9 [doi] PST - ppublish SO - Arch Toxicol. 2010 Mar;84(3):233-43. doi: 10.1007/s00204-009-0489-9.